Xu Guodong, Feng Feng, Chen Wang, Xiao Yong, Fu Yigang, Zhou Siyu, Duan Shaofeng, Li Manman
Department of Radiology, The Yancheng Clinical College of Xuzhou Medical University, The First people's Hospital of Yancheng, Yancheng 224006, Jiangsu Province, China.
Department of Radiology, Affiliated Tumor Hospital of Nantong University, Nantong 226001, Jiangsu Province, China.
Acad Radiol. 2025 Jan;32(1):120-131. doi: 10.1016/j.acra.2024.07.051. Epub 2024 Aug 10.
To develop and validate a radiomics nomogram utilizing CT data for predicting perineural invasion (PNI) and survival in gastric cancer (GC) patients.
A retrospective analysis of 408 GC patients from two institutions: 288 patients from Institution I were divided 7:3 into a training set (n = 203) and a testing set (n = 85); 120 patients from Institution II served as an external validation set. Radiomics features were extracted and screened from CT images. Independent radiomics, clinical, and combined models were constructed to predict PNI. Model discrimination, calibration, clinical utility, and prognostic significance were evaluated using area under the curve (AUC), calibration curves, decision curves analysis, and Kaplan-Meier curves, respectively.
15 radiomics features and three clinical factors were included in the final analysis. The AUCs of the radiomics model in the training, testing, and external validation sets were 0.843 (95% CI: 0.788-0.897), 0.831 (95% CI: 0.741-0.920), and 0.802 (95% CI: 0.722-0.882), respectively. A nomogram was developed by integrating significant clinical factors with radiomics features. The AUCs of the nomogram in the training, testing, and external validation sets were 0.872 (95% CI: 0.823-0.921), 0.862 (95% CI: 0.780-0.944), and 0.837 (95% CI: 0.767-0.908), respectively. Survival analysis revealed that the nomogram could effectively stratify patients for recurrence-free survival (Hazard Ratio: 4.329; 95% CI: 3.159-5.934; P < 0.001).
The radiomics-derived nomogram presented a promising tool for predicting PNI in GC and held significant prognostic implications.
The nomogram functioned as a non-invasive biomarker for determining the PNI status. The predictive performance of the nomogram surpassed that of the clinical model (P < 0.05). Furthermore, patients in the high-risk group stratified by the nomogram had a significantly shorter RFS (P < 0.05).
利用CT数据开发并验证一种放射组学列线图,用于预测胃癌(GC)患者的神经周围侵犯(PNI)及生存情况。
对来自两家机构的408例GC患者进行回顾性分析:机构I的288例患者按7:3分为训练集(n = 203)和测试集(n = 85);机构II的120例患者作为外部验证集。从CT图像中提取并筛选放射组学特征。构建独立的放射组学、临床及联合模型来预测PNI。分别使用曲线下面积(AUC)、校准曲线、决策曲线分析和Kaplan-Meier曲线评估模型的区分度、校准度、临床实用性及预后意义。
最终分析纳入了15个放射组学特征和3个临床因素。放射组学模型在训练集、测试集和外部验证集中的AUC分别为0.843(95%CI:0.788 - 0.897)、0.831(95%CI:0.741 - 0.920)和0.802(95%CI:0.722 - 0.882)。通过将显著临床因素与放射组学特征整合,开发了一种列线图。该列线图在训练集、测试集和外部验证集中的AUC分别为0.872(95%CI:0.823 - 0.921)、0.862(95%CI:0.780 - 0.944)和0.837(95%CI:0.767 - 0.908)。生存分析显示,列线图可有效对患者进行无复发生存分层(风险比:4.329;95%CI:3.159 - 5.934;P < 0.001)。
基于放射组学的列线图为预测GC中的PNI提供了一种有前景的工具,并具有重要的预后意义。
列线图可作为确定PNI状态的非侵入性生物标志物。列线图的预测性能优于临床模型(P < 0.05)。此外,根据列线图分层的高危组患者无复发生存期显著缩短(P < 0.05)。